Brandon M. White was mentioned as counsel for Mylan Inc. in "Mylan Nabs AIA Review Of 2 Patents For Teva's Copaxone," a Law360 article, regarding the granted reviews of two patents licensed to Teva Pharmaceuticals USA Inc. for its multiple sclerosis drug Copaxone.